Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   168,823    

Indirect Shares

   417,826      
Direct Value   $5,035,310    

Indirect Value

   $13,780,226      
Total Shares   586,649      
Total Value   $18,815,536      


Agios Pharmaceuticals Inc $4,464,514 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,172 Denali Therapeutics Inc. $288,218 Regeneron Pharmaceuticals Inc $276,405 Agios Pharmaceuticals Inc $4,464,514 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,172 Denali Therapeutics Inc. $288,218 Regeneron Pharmaceuticals Inc $276,405
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 35.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2023-06-01 15,529 2023-06-01 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-04 4 AS $70.14 $5,611,200 D/D (80,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-23 4 AS $90.11 $4,463,524 D/D (49,374) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-30 4 AS $90.07 $4,109,534 D/D (45,626) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-16 4 AS $71.77 $3,877,218 D/D (53,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-26 4 AS $62.68 $3,760,800 I/I (60,000) 137,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-23 4 AS $80.01 $2,630,329 D/D (32,875) 0 0 -
FMI Foundation Medicine, Inc. Director   –       •      –    2015-04-07 4/A D $50.00 $2,599,600 I/I (51,992) 5,254 0 -
FMI Foundation Medicine, Inc. Director   –       •      –    2015-04-07 4 D $50.00 $2,521,800 I/I (50,436) 6,032 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2024-02-27 4 S $33.60 $2,403,592 D/D (69,329) 122,854 0 %
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-18 4 AS $67.12 $2,349,200 D/D (35,000) 0 0 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2020-12-21 4 AS $90.06 $2,251,555 D/D (25,000) 0 0 %
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2024-02-27 4 OE $31.64 $2,193,570 D/D 69,329 180,325 0 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2020-11-12 4 AS $70.05 $2,101,590 D/D (30,000) 25,000 0 %
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-26 4 AS $80.35 $1,911,494 D/D (23,572) 0 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2024-02-23 4 S $33.05 $1,577,510 D/D (47,731) 122,854 0 %
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-06-01 4 AS $120.67 $1,568,710 I/I (13,000) 232,272 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2024-02-23 4 OE $31.64 $1,510,209 D/D 47,731 170,585 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-02 4 AS $60.55 $1,453,200 D/D (24,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-01-02 4 AS $110.08 $1,431,040 I/I (13,000) 111,772 0 -
FMI Foundation Medicine, Inc. Director   –       •      –    2015-04-07 4/A D $50.00 $1,299,800 D/D (25,996) 5,254 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-12-01 4 AS $97.03 $1,261,390 I/I (13,000) 118,272 0 -
FMI Foundation Medicine, Inc. Director   –       •      –    2015-04-07 4 D $50.00 $1,260,900 D/D (25,218) 6,032 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-06-01 4 AS $94.37 $1,239,608 D/D (13,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-02 4 AS $114.31 $1,188,824 I/I (10,400) 107,872 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 AS $80.01 $1,082,775 D/D (13,533) 0 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us